October 26, 2018

Laurie Goodman, PhD

CEO

ClearLight Biotechnologies, LLC

MMRI Building

428 Oakmead Parkway

Sunnyvale, CA 94085

Re: Amendment #10 to Sponsored Research Agreement (SRA) dated June 10, 2015 and effective July 1, 2015, further modified in Amendment #1 to a start date of July 15, 2015 and modified subsequently as Amendments #2-9

Dear Dr. Goodman:

Pursuant to your recent communication (email attached dated September 19, 2018) in which you notified MMRI of a change of your organization's name, MMRI provides the following amendment in order to accommodate and pursue our research activities. The following modification to our Agreement is presented as Amendment #10.

Effective October I, 2018 it is noted that, ClearLight Diagnostics, LLC is to operate as ClearLight Biotechnologies, LLC.

428 Oakmead Parkway Sunnyvale, CA 94085
Telephone (408) 523-6260 FAX (408) 523-6261

February 9, 2021

Al Hansen

President

Clearlight Biotechnologies, Inc.

MMRI Building

428 Oakmead Parkway

Sunnyvale, CA 94085

Re: Amendment #11 to Sponsored Research Agreement (SRA) dated June 10, 2015 and effective July 1, 2015, further modified in Amendment #1 to a start date of July 15, 2015 and modified subsequently as Amendments #2-10

Dear Mr. Hansen:

Pursuant to your recent communication in which you notified MMRI of a change of your organization's name, MMRI provides the following amendment in order to accommodate and pursue our research activities. The following modification to our Agreement is presented as Amendment #11.

Effective February 9, 2021 it is noted that, ClearLight Biotechnologies, LLC is to operate as Clearlight Biotechnologies, Inc.

Sincerely yours,

Edward P Amento, MD

Executive Director and President

428 Oakmead Parkway Sunnyvale, CA 94085

Telephone (408) 523-6260 FAX (408) 523-6261